Productive replication of nephropathogenic infectious bronchitis virus in peripheral blood monocytic cells, a strategy for viral dissemination and kidney infection in chickens by Avalakuppa Papi Reddy, Vishwanatha Reddy et al.




of nephropathogenic infectious bronchitis virus 
in peripheral blood monocytic cells, a strategy 
for viral dissemination and kidney infection 
in chickens
Vishwanatha R. A. P. Reddy*, Ivan Trus, Lowiese M. B. Desmarets, Yewei Li, Sebastiaan Theuns 
and Hans J. Nauwynck
Abstract 
In the present study, the replication kinetics of nephropathogenic (B1648) and respiratory (Massachusetts-M41) IBV 
strains were compared in vitro in respiratory mucosa explants and blood monocytes (KUL01+ cells), and in vivo in 
chickens to understand why some IBV strains have a kidney tropism. B1648 was replicating somewhat better than 
M41 in the epithelium of the respiratory mucosa explants and used more KUL01+ cells to penetrate the deeper layers 
of the respiratory tract. B1648 was productively replicating in KUL01+ monocytic cells in contrast with M41. In B1648 
inoculated animals, 102.7–6.8 viral RNA copies/100 mg were detected in tracheal secretions at 2, 4, 6, 8, 10 and 12 days 
post inoculation (dpi), 102.4–4.5 viral RNA copies/mL in plasma at 2, 4, 6, 8, 10 and 12 dpi and 101.8–4.4 viral RNA cop-
ies/106 mononuclear cells in blood at 2, 4, 6 and 8 dpi. In M41 inoculated animals, 102.6–7.0 viral RNA copies/100 mg 
were detected in tracheal secretions at 2, 4, 6, 8 and 10 dpi, but viral RNA was not demonstrated in plasma and mono-
nuclear cells (except in one chicken at 6 dpi). Infectious virus was detected only in plasma and mononuclear cells of 
the B1648 group. At euthanasia (12 dpi), viral RNA and antigen positive cells were detected in lungs, liver, spleen and 
kidneys of only the B1648 group and in tracheas of both the B1648 and M41 group. In conclusion, only B1648 can eas-
ily disseminate to internal organs via a cell-free and -associated viremia with KUL01+ cells as important carrier cells.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Avian infectious bronchitis virus (IBV) causes mild to 
acute respiratory disease in chickens, characterized by 
coughing, sneezing, tracheal rales and dyspnea [1]. IBV 
belongs to the order of the Nidovirales, family Corona-
viridae, subfamily Coronavirinae and genus Gammacoro-
navirus [2]. Worldwide, IBV causes huge economic losses 
in both broilers and layers. IBV has a tropism not only 
for the epithelium of the respiratory tract but also for 
the epithelium of kidneys, oviduct, gastrointestinal tract 
(oesophagus, proventriculus, duodenum, jejunum, bursa 
of Fabricius, caecal tonsils, rectum and cloaca) and testes 
[3, 4]. IBV is clinically associated with poor performance 
of birds, reduced egg production and quality, as well as 
increased predisposition to other secondary bacterial 
infection [5]. IBV is highly contagious. Currently, multi-
ple serotypes of IBV exist, and new variants emerge due 
to frequent point mutations and recombination events in 
the viral genome [4]. Vaccination failure is very common 
against IBV due to poor or no cross-protection between 
different IBV serotypes.
The first IBV was isolated from birds showing respira-
tory problems in the United States in 1931 [6]. In the 
early 1950s, the well-known respiratory Massachusetts 
type of IBV (Mass) was isolated in the United States. In 
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subsequent years, Mass-type (prototype: M41) strains 
have been identified worldwide, and many variants 
emerged. Some IBV strains were called nephropatho-
genic because the initial respiratory infection was fol-
lowed by severe kidney infection. Important clinical signs 
of nephropathogenic IBV strains include increased water 
consumption, low body weight gain, watery droppings 
and significant mortality. Necropsy of birds that died 
during a nephropathogenic infection reveals enlarged 
and pale kidneys with urates in the collecting tubules [7]. 
In the 1960s, the first nephropathogenic IBV strains were 
reported in the US and Australia, and later worldwide. In 
the last 15 years, nephropathogenic IBV strains have been 
emerging as most prevalent IBV strains in commercial 
poultry [8–12]. The B1648 strain is a Belgian reference 
nephropathogenic IBV serotype, that was responsible 
for large outbreaks of kidney disease in broiler farms in 
Belgium, The Netherlands and Northern France, and was 
first isolated in 1984 [7, 13–15].
In September 2012, a novel coronavirus emerged in 
humans, designated Middle East respiratory syndrome 
coronavirus (MERS-CoV). MERS-CoV has a higher mor-
tality rate (>35%) than another well-known coronavi-
rus, the severe acute respiratory syndrome coronavirus 
(SARS-CoV) (9.6%). The MERS-CoV infected patients 
usually end up with a severe pneumonia complicated 
with kidney failure. The severity of MERS-CoV infec-
tions in humans, caused by its extra-pulmonary infection 
of kidneys have prompted us to question why this virus 
has a strong tropism for the kidneys. The same ques-
tion has been raised for the kidney tropism of certain 
IBV strains, for the past 25  years [7, 13–15]. Hence, in 
the present study, we aimed to explore the tissue tropism 
characteristics of IBV nephropathogenic (B1648) and 
respiratory (M41) strains in chickens. To this end, rep-
lication kinetics of IBV B1648 and M41 were evaluated 
in  vitro in tracheal mucosa explants and blood mono-
cytes by a reproducible quantitative analysis system using 
confocal microscopy [16–18]. A new 5′ RT-qPCR was 
validated and used for comparing in vivo the viral repli-
cation kinetics in the respiratory tract and dissemination 
in blood of IBV B1648 and M41 [19]. Elucidating the tis-
sue tropism mechanisms of B1648 and M41 is important 
to plan better prevention strategies for emerging highly 
nephropathogenic IBV infections.
Materials and methods
IBV B1648 and M41 replication characteristics in tracheal 
mucosa explants and peripheral blood monocytes
Viruses
The virulent nephropathogenic IBV B1648 and the res-
piratory prototype M41 were used in this study. B1648 
is a Belgian field isolate obtained in 1984 and described 
previously [13, 15, 20]. M41 with unknown passage his-
tory was obtained from the avian pathology laboratory, 
Ghent University [21]. Virus was propagated in specific 
pathogen free (SPF) 10  days old embryonated chicken 
eggs. From both B1648 and M41, a second passage was 
produced and utilized in the present experiment. The 
allantoic fluids were harvested 48 h after infection, clari-
fied by low-speed centrifugation and stored at −70  °C. 
Virus titration was performed in 10  days old chicken 
embryos by inoculation of 10-fold dilutions via allantoic 
route and expressed as 50% egg infectious dose per mL 
(EID50/mL).
Virus titration
Intracellular and extracellular virus titers were deter-
mined by an EID50 assay using embryonated chicken 
eggs. Embryonated chicken eggs were obtained from 
an SPF flock and used when the embryos were 10  days 
old. Ten-fold dilutions of virus were prepared in PBS 
(1 ×  Dulbecco’s phosphate buffered saline (DPBS) with 
0.9 mM CaCl2, 0.5 mM MgCl2 × 6H2O and 20 mg/L phe-
nol red) [4] and 100 μL of the dilutions were inoculated 
into the allantoic cavity of eggs. Eggs were incubated at 
37 °C for 7 days. The embryos were collected and exam-
ined for the presence of embryo dwarfing and curling, 
which is characteristic for an IBV infection. Based on the 
observations, end points were calculated [7, 22]. Virus 
titers were assessed by a fifty percent end-point, accord-
ing to the method of Reed and Muench, and expressed as 
EID50/mL.
Isolation and cultivation of chicken tracheal mucosa explants
This study was performed in agreement with the guide-
lines of the local Ethical and Animal Welfare Committee 
of the Faculty of Veterinary Medicine and Bio-Science 
Engineering of Ghent University. The chicken tracheal 
mucosa explants were prepared as described previously 
[23]. Briefly, three eight-week-old specific-pathogen free 
(SPF) chickens were euthanized by intravenous injection 
of sodium pentobarbital (100 mg/kg) in the brachial wing 
vein. Tracheas were collected and carefully split into two 
equal halves with surgical blades (Swann–Morton). Tra-
cheal mucosal explants covering a total area of 10  mm2 
were made and placed on top of fine-meshed gauzes in 
six-well culture plates (Nunc), epithelium upwards. The 
explants were maintained in serum-free medium [50% 
Ham’s F12 (Gibco)/50% DMEM (Gibco)] supplemented 
with 100 U/mL penicillin (Continental Pharma), 0.1 mg/
mL streptomycin (Certa), 1  μg/mL gentamycin (Gibco) 
and 25  mM HEPES (Gibco). The epithelium of the 
explants was slightly immersed in the fluid to achieve an 
air liquid interface. Explants were maintained up to 96 h 
at 37 °C and 5% CO2.
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Isolation of blood monocytes
Five mL blood was collected on heparin (15  U/mL) 
(Leo) from the brachial wing vein of three chickens. 
Monocytes were isolated from chicken peripheral blood 
mononuclear cells (PBMC) by Ficoll-paque gradient cen-
trifugation as described by the manufacturer (Pharma-
cia Biotech AB). Mononuclear cells were resuspended 
in RPMI-1640 (Gibco) medium containing 10% fetal calf 
serum (FCS, Gibco), 100  U/mL penicillin (Continen-
tal Pharma), 0.1  mg/mL streptomycin (Certa), 1  μg/mL 
gentamycin (Gibco), and 1% non-essential amino acids 
(Gibco). Afterwards, 2 ×  106 cells/mL were seeded in a 
24-well plate (Nunc) and cultivated at 37 °C with 5% CO2. 
Non-adherent cells were removed by washing two times 
with RPMI-1640 medium at 2 and 24  h after seeding. 
The adherent cell population consisted of 80.2 ± 7.3% of 
monocytes, based on the fluorescent staining with the 
monocyte/macrophage marker KUL01 [24]. KUL01+ 
cells were cultured up to 96 h at 37 °C and 5% CO2. All 
experiments were performed in triplicate.
IBV inoculation and sample collection of tracheal mucosa 
explants and monocytes
Tracheas of three chickens were used. Explants were 
inoculated with IBV B1648 and M41 at 24  h of cultiva-
tion. For the inoculation, explants were taken from their 
gauze and placed at the bottom of a 24-well plate with the 
epithelial surface upwards. Explants were washed twice 
with warm serum-free medium and inoculated with 1 mL 
of a virus stock containing 107.0 EID50 (1  h, 37  °C, 5% 
CO2). In in vitro tracheal mucosa experiments, the local 
mucus layer and other innate defense barriers reduce 
infectivity of the mucosa. Therefore, the mucosal explants 
were washed before inoculation to remove mucus and 
other innate defense barriers and high virus titers were 
used (107 EID50/mL) in order to have sufficient virus to 
reach the epithelial cells. In addition, the main aim of this 
study was to evaluate replication kinetics at early time 
points, before the viability of the mucosal explants goes 
down, i.e. 96 h of cultivation and 72 h after virus inocula-
tion. To meet the above expectations, the use of a high 
virus titer for the inoculation of in vitro mucosal explants 
is a general standardized protocol in our laboratory [17, 
25, 26]. After 1  h of virus incubation, the inoculated 
explants were washed three times with warm medium 
and placed back on the gauze. Explants were collected at 
0, 6, 12, 24, 48 and 72 h post-inoculation (hpi), embedded 
in Methocel® (Fluka) and frozen at −70 °C.
Monocytes were inoculated with IBV B1648 and M41 
at a multiplicity of infection (m.o.i.) of 5. To maintain 
uniformity and consistency, the virus titer of inoculum, 
incubation time, washing steps and sample collection 
time points should be similar in TOC and monocyte 
cultures under in  vitro conditions. Therefore, the same 
virus titer was used to inoculate in vitro cultured mono-
cytes. After 1 h of virus incubation (37 °C, 5% CO2), cells 
were washed three times with warm RPMI-1640 medium 
and further incubated in medium. Cells and superna-
tant were collected at 0, 6, 12, 24, 48 and 72 hpi for viral 
antigen quantification and virus titration. The cells were 
removed from the well by scraping and added to the pel-
let for determination of intracellular virus titers. Virus 
was released from the cells by 2 freeze–thaw cycles. The 
supernatants were used for determination of extracellular 
virus titers. The samples were stored at −70 °C until virus 
titration on embryonated eggs.
Identification and quantification of IBV infected cells in the 
tracheal mucosa explants and monocytes
A double immunofluorescence staining was performed to 
identify and quantify individual IBV-positive cells. At 0, 
6, 12, 24, 48 and 72  hpi, 15 consecutive cryosections of 
10 μm were made from the frozen tracheal explants and 
fixed (4% paraformaldehyde for 10 min and 0.1% Triton® 
X-100 for 2  min). The cryosections were first stained 
for monocytes/macrophages (KUL01 marker), and next 
for IBV antigens. The cryosections were incubated (1 h, 
37  °C) with mouse monoclonal anti-chicken monocyte/
macrophage (KUL01) antibodies (Southern Biotech) 
(1:250 in PBS containing 10% negative goat serum) and 
washed three times after incubation. Cryosections were 
then incubated (1 h, 37 °C) with Texas Red-labelled goat 
anti-mouse IgG1 antibodies (Molecular Probes) (1:250 in 
PBS containing 10% negative goat serum and 10% nega-
tive chicken serum). Subsequently, after washing, the sec-
tions were incubated (1 h, 37  °C) with a polyvalent IBV 
hyperimmune serum conjugated with FITC [14, 20] (1:20 
in PBS for B1648; 1:7 in PBS for M41). Finally, after wash-
ing, the sections were incubated [10 min, room temper-
ature (RT)] with Hoechst 33342 (1:100 in PBS), washed 
and mounted with glycerin-DABCO (Janssen Chimica).
Based on cross serum neutralization tests, B1648 is dis-
tantly related to respiratory IBV strains. FITC-conjugated 
antibodies were prepared from a polyclonal hyperim-
mune serum against B1648 strain, and their reactivity 
against B1648 infected cells was quite different from the 
reactivity against M41 infected cells [14, 20]. As a result, 
the concentration of FITC-conjugated polyclonal anti-
B1648 antibodies that is needed to detect IBV-positive 
cells was higher for M41 than for B1648 [21]. The IBV-
positive cell quantification done with FITC-conjugated 
polyclonal anti-B1648 antibodies was confirmed by 
monoclonal antibodies directed against the nucleocap-
sid protein [27]. The number of virus-infected cells was 
determined in 15 consecutive cryosections in both the 
epithelium and lamina propria of the tracheal mucosa 
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explants. Further, at each time point, the number of 
infected KUL01+ cells was calculated both in the epithe-
lium and lamina propria.
Monocytes were fixed in 4% paraformaldehyde for 
10 min and 0.1% Triton® X-100 for 2  min at 0, 6, 12, 
24, 48 and 72 hpi. IBV-positive cells in monocytes were 
visualized using the same technique as for the cryosec-
tions. The percentage of B1648 and M41-positive cells 
was determined for the KUL01+ cells (colocalization). A 
reproducible quantitative analysis system was followed 
for the elucidation of IBV replication in the tracheal 
mucosal explants and blood monocytes/macrophages 
(KUL01+ cells) by using a confocal microscopy (Leica 
TCS SPE confocal microscope) [16–18].
Replication kinetics of IBV B1648 and M41 in chickens
Experimental design
The experimental setup is presented in Table  1. Nine 
3-week-old SPF White Leghorn chickens were indi-
vidually tagged and 3 chickens per group were housed 
in separate negative pressure (150  pa) isolation units 
(IM 1500, Montair). Before the start of the experiment, 
an acclimatization period of two-weeks was respected. 
Drinking water and food were provided ad  libitum. The 
experimental design was evaluated and approved by the 
Ethical and Animal Welfare Committee of the Faculty of 
Veterinary Medicine of Ghent University (EC 2014/160).
Virus inoculation
Three 5-week-old chickens were inoculated with the viru-
lent nephropathogenic B1648 strain or respiratory M41 
via intratracheal (200 μL), nasal (50 μL each nostril) and 
ocular routes (50  μL each eye) with 103 EID50/400  μL. 
The main aim of our in vivo study was to study the rep-
lication kinetics of IBV in the respiratory mucosa and its 
spread via blood to internal organs (0 to 12 dpi). To con-
duct this in vivo study successfully, mortality should not 
be induced. Based on our experience of past experiments 
and available literature, we have selected 103 EID50/400 μL 
to keep the chance of mortality at a minimal level [20, 28, 
29]. The control chickens were mock inoculated with PBS 
and served as a negative control group.
Clinical signs and water consumption
Clinical signs, such as depression, huddling together, 
ruffled feathers, sneezing, coughing, tracheal rales and 
dyspnoea were recorded daily from −3 until 12 days post 
inoculation (dpi). Waterers were regularly weighed in 
each group to calculate water consumption per bird.
Post mortem findings
At 12 dpi, the chickens from the three groups were 
humanely euthanized. During necropsy, all tissues were 
examined macroscopically. After macroscopical exami-
nation, two samples were collected from the following 
tissues: trachea, lungs, liver, spleen and kidneys. The first 
tissue sample was stored at −70 °C for viral RNA quan-
tification by RT-qPCR. The second tissue sample was 
embedded in Methocel® (Fluka) and was snap frozen for 
immunofluorescence staining.
Standardization of SYBR green‑based RT‑qPCR assay for ORF 
1a gene
To avoid the detection of subgenomic mRNAs, the real-
time 5′ RT-qPCR primers were designed by targeting the 
highly conserved region of open reading frame (ORF) 1a 
of B1648 strain (Table 2). Then, a single step SYBR green-
based 5′ RT-qPCR assay was developed for ORF1a gene.
Primer design and in silico validation
Multiple sequence alignments were performed with the 
relevant IBV sequences of GenBank in the MEGA soft-
ware version 5.2.2. The real-time RT-qPCR primers were 
designed using the online web tool Primer 3 plus. The 
sequences of the primers for real-time RT-qPCR tar-
geting ORF 1a and amplicon size are listed in Table  2. 
Primer-specificity was assessed in silico by use of the 
Basic Local Alignment Search Tool (BLAST) in pub-
lic databases and by aligning these primers to ORF 1a 
genes of pan IBV strains of the worldwide. The risk of 
primer-dimer formation, and the presence of hairpins 
at the annealing site were analyzed using OligoAnalyzer 
3.1 (Integrated DNA Technologies) with a correction for 
ion concentrations set at 50 mM for Na+ and 3 mM for 
Mg2+. All primers used in this study were synthesized by 
Table 1 Experimental design of in vivo IBV (B1648/M41) infection study
a Peripheral blood mononuclear cells.
Group Number of animals Time of inoculation (days post inoculation)
Virus strain Observation of clinical signs Tracheal swab collection Blood collection (plasma and PBMCa) Euthanasia
B1648 3 −3 to 12 0, 2, 4, 6, 8, 10, 12 0, 2, 4, 6, 8, 10, 12 12
M41 3 −3 to 12 0, 2, 4, 6, 8, 10, 12 0, 2, 4, 6, 8, 10, 12 12
PBS control 3 −3 to 12 0, 2, 4, 6, 8, 10, 12 0, 2, 4, 6, 8, 10, 12 12
Page 5 of 19Reddy et al. Vet Res  (2016) 47:70 
Integrated DNA Technologies and purified by standard 
desalting.
Preparation of RNA standards for absolute quantification
Standard RNA for absolute quantification was prepared 
from B1648. Viral RNA of the B1648 was extracted using 
the QIAamp Viral RNA Mini Kit (Qiagen). A synthetic 
fragment containing the amplicon size of 254 nt of ORF 
1a gene was generated in  vitro to prepare the standard 
RNA for absolute quantification. The RNA was reverse-
transcribed into cDNA with the QIAGEN OneStep RT-
PCR Kit (Qiagen), using primer set ORF  1a cDNA_fw/
cDNA_rv (Table 2). ORF 1a cDNA_fw primer was modi-
fied to T7_fw with a T7 promoter sequence at its 5′ end 
by Herculase II fusion DNA polymerase (Agilent Tech-
nologies Inc., Santa Clara, CA, USA). The T7 promoter 
sequence incorporation was necessary for subsequent 
in  vitro transcription (Table  2). A 50  μL OneStep RT-
PCR (Qiagen) reaction mixture consisting 10 μL OneStep 
RT-PCR buffer (Qiagen), 2 μL dNTP (10 mM) mix, 3 μL 
forward primer (10  μM), 3  μL reverse primer (10  μM), 
2 μL OneStep RT-PCR enzyme mix, 20 μL nuclease free 
water and 10 μL RNA. To generate the cDNA fragment, 
a reverese transcription step of 30  min at 50  °C and an 
enzyme activation step of 15 min at 95 °C were followed 
by 35 cycles each denaturation 30  s at 94  °C, annealing 
30 s at 48 °C and extension 1 min at 72 °C. A final exten-
sion step was performed for 10 min at 72 °C and stored at 
4  °C until further processing. Then, the cDNA fragment 
was analyzed by 2% agarose gel electrophoresis, and frag-
ments with the correct length were excised and purified 
from gel using the Nucleospin Gel and PCR-Clean up kit 
(Macherey–Nagel). The cDNA was either used directly 
for in  vitro transcription or stored at −70  °C. In  vitro 
transcription of RNA was performed by incubation 
for 1  h at 37  °C with 10×  transcription buffer, 500  μM 
rNTPs and 20 U T7 RNA Polymerase-Plus Enzyme Mix 
(Applied Biosystems). Template DNA was removed by 
treatment with enzyme 2U DNase I (Sigma Aldrich) for 
15 min at 37 °C. Then, enzyme DNase I inactivation was 
done for 10 min at 75  °C. Finally, the in vitro generated 
RNA was purified using the RNeasy Mini Kit (Qiagen) 
and the amount of RNA was determined using the Nan-
odrop 2000 Spectrophotometer (Thermo Scientific). 
RNA standards were stored in single-use aliquots of 20 
μL (8  ng/μL, 5.27 ×  1010 copies/μL) volume at −70  °C. 
Ten microliters of RNA was used for preparation of a 
standard curve, and the remainder (6  μL) was used to 
determine the RNA concentration with the Nanodrop 
2000 Spectrophotometer. The ENDMEMO online web 
tool was used to calculate the number of RNA copies per 
microliter.
SYBR green based one step RT‑qPCR protocol
In order to generate a standard curve, the concentration 
of RNA was measured as described above, and further 
serially ten-fold diluted in nuclease free water (Gibco). 
RT-qPCR reaction mixtures (20  μL) consisted of 10  μL 
Precision OneStep qRT-PCR Mastermix with SYBR 
Green and ROX (Primer Design), 200  nM (0.4  μL/reac-
tion) of each primer (qPCR_fw and qPCR_rv), 6.2  μL 
nuclease free water and 3 μL of standard RNA template 
or H2O. Reaction mixtures were loaded in MicroAmp 
Optical 96-well reaction plates (Applied Biosystems), 
sealed with MicroAmp Optical Adhesive Films (Applied 
Biosystems), and experiments were performed in a Ste-
pOnePlus apparatus (Applied Biosystems). A reverse 
transcription step of 10 min at 55 °C and an enzyme acti-
vation step at 95 °C for 8 min were followed by 40 cycles, 
each 10 s at 95 °C and 60 s at 58 °C. Afterwards, a first-
derivative melting curve analysis was performed by heat-
ing the mixture to 95  °C for 15 s, then cooling to 60  °C 
for 1 min, and heating back to 95 °C at 0.3 °C increments. 
Results were analyzed using the StepOnePlus Software 
version 2.2. The baseline was set automatically, and the 
threshold was placed manually in the exponential phase 
of the amplification reaction. Melt curve analysis and 
agarose gel electrophoresis were performed to assess 
specificity of the reactions. Amplification efficiency was 
determined by running a standard curve over a linear 
dynamic range (LDR) from 7 log10 copies/reaction to 1 
log10 copies/reaction in 1:10 dilution steps. Each dilution 
Table 2 Primers used for real-time RT-PCR of ORF 1a
Primer name Gene Primer sequence Amplicon
Size
cDNA_fw ORF 1a 5′-GGT GTT AGG CTT ATA GTT CCT CAG-3′ 254 nt
cDNA_rv ORF 1a 5′-TAA ACA TTA GGG TTG ACA CCA GT-3′
T7_fw ORF 1a 5′-TAA TAC GAC TCA CTA TAG GGG GTG TTA GGC TTA TAG TTC CTC AG-3′
qPCR_fw ORF 1a 5′-GCT ATT GTA GAG GTA GTG TAT GTG AG-3′ 176 nt
qPCR_rv ORF 1a 5′-AGG GTT GAC ACC AGT AAA GAA T-3′
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point of the standard curve was analyzed in triplicate and 
also three non-template control reactions (nuclease free 
water) were included in each experiment.
Collection of tracheal secretions, plasma and PBMCs
Tracheal secretions and 2  mL of blood [with EDTA 
(VWR)] were collected from each chicken at 0, 2, 4, 6, 
8, 10 and 12  dpi. Immediately after collection, tracheal 
secretions were immersed in transport medium contain-
ing PBS [1 × Dulbecco’s PBS (DPBS) with 0.9 mM CaCl2, 
0.5  mM MgCl2 ×  6H2O and 20  mg/L phenol red] sup-
plemented with 10% FCS, 1000 U/mL penicillin, 1  mg/
mL streptomycin and 0.5 mg/mL kanamycin. Plain swabs 
were weighed before and after swabbing, and viral RNA 
copies were calculated per 100 mg of secretions. Plasma 
was harvested from blood after centrifugation (300  g, 
10 min) and the remaining pellet was used for isolation of 
PBMCs (mononuclear cells). Mononuclear cells were iso-
lated by Ficoll-paque gradient centrifugation as described 
above (section “IBV B1648 and M41 replication charac-
teristics in tracheal mucosa explants and peripheral blood 
monocytes”). Infection in mononuclear cells was evalu-
ated by three methods. With the first method, 200 000 
mononuclear cells were used to make cytospins and to 
perform immunostainings (protocol was described in 
section “IBV B1648 and M41 replication characteristics 
in tracheal mucosa explants and peripheral blood mono-
cytes”), to quantitate the number of viral antigen posi-
tive cells. With the second method and third method, 106 
mononuclear cells were lysed by one freeze–thaw cycle 
to determine the number of viral RNA copies by RT-
qPCR, and to confirm the presence of infectious virus by 
virus isolation, respectively. Plasma and 106 mononuclear 
cells were stored at −70 °C until use.
RT‑qPCR in tracheal secretions, plasma and mononuclear 
cells
Viral RNA was extracted from tracheal secretions, 
plasma and mononuclear cells using the QIAamp Viral 
RNA Mini Kit (Qiagen). Three μL of RNA was used per 
RT-qPCR reaction. Viral RNA extracts from tracheal 
secretions, plasma and mononuclear cells were analyzed 
in duplicate RT-qPCR reactions as described above.
Virus isolation in plasma and mononuclear cells
Virus isolation from the plasma and 106 mononuclear 
cells samples were performed on 10  days old embryo-
nated SPF eggs, to confirm the presence of infectious 
virus (protocol described in section “IBV B1648 and M41 
replication characteristics in tracheal mucosa explants 
and peripheral blood monocytes”). If embryo dwarf-
ing and curling lesions were not observed after the first 
inoculation, up to five blind passages of the samples were 
performed.
RT‑qPCR and immunofluorescence staining of tissues
RNA was extracted from tissues using the QIAamp cador 
Pathogen Mini Kit (Qiagen). Quantification of the num-
ber of viral RNA copies in tissues (RNA copies/g) was 
similar like in other samples. IBV-positive cells in tissues 
were visualized and quantified using the same technique 
as for the cryosections of tracheal mucosa explants. 
Twenty consecutive cryosections of 10  μm were ana-
lyzed per tissue. The average number of infected cells was 
expressed per 10 mm2 of tissue.
Statistical analysis
SigmaPlot (Systat Software, Inc.) software was used to 
analyse the data statistically with one-way analysis of 
variance (ANOVA). Viral loads in tracheal secretions, 
plasma and mononuclear cells were log-transformed 
prior to analysis. The quantification limit of RT-qPCR 
was 3.4 log10 copies/mL (quantification limit is the con-
centration/amount of viral RNA copies, which can be 
quantified reliably). The detection limit of RT-qPCR 
was 2.4 log10 copies/mL (detection limit is the mini-
mal concentration of viral that can be detected). The 
results of three independent experiments were shown as 
mean ± standard deviation (SD). P values of <0.05 were 
considered to be significant.
Results
IBV B1648 and M41 replication characteristics 
in respiratory mucosa and KUL01+ cells
B1648 and M41 replication in tracheal mucosa explants
Inoculation of chicken tracheal mucosa explants with 
IBV B1648 and M41 led to the appearance of viral anti-
gen positive (infected) cells in the epithelium and lam-
ina propria of the tracheal mucosa starting from 6  hpi 
(Figure 1). In the epithelial layer of the tracheal mucosa, 
the number of B1648 and M41 infected cells gradually 
increased until 12 hpi, and later gradually decreased up 
to 72  hpi (Figure  1A). The number of B1648 infected 
cells in the epithelium was significantly higher than M41 
infected cells at 6 [B1648: 2856.3 ± 217.2 (which equals 
37.2 ±  2.8% of the epithelial cells), M41: 877.0 ±  142.7 
(11.2 ±  2.9%), P =  0.0002)], 12 [B1648: 6490.3 ±  298.9 
(82.5  ±  4.1%), M41: 4380.0  ±  203.1 (57.6  ±  3.4%), 
P  =  0.0005] and 24  hpi [B1648: 4077.3  ±  225.4 
(51.8  ±  4.8%), M41: 3064.3  ±  144.9 (38.9  ±  3.0%), 
P = 0.0028]. The number of M41 infected cells was sig-
nificantly higher than B1648 infected cells at 48  hpi 
(B1648: 664.7 ± 164.7, M41: 1446.7 ± 354.3, P = 0.0257) 
and were slightly higher at 72 hpi (B1648: 130.0 ± 62.4, 
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M41: 179.3 ± 67.6, P = 0.4057). From 48 hpi, the epithe-
lial layer was almost totally gone, which explained the 
drop of positive cells.
In the lamina propria of the tracheal mucosa, B1648 
and M41 infected cells were visible from 6  hpi and 
increased in number over time (Figure 1A). In the lamina 
propria, the average number of B1648 infected cells was 
only slightly higher than M41 infected cells at 6, 12, 24 
and 48 hpi (P = 0.6433–0.1578) but significantly higher 
at 72 hpi (P = 0.0249).
Double immunofluorescence staining was performed 
for the identification of IBV susceptible cells. IBV 
infected KUL01+ cells were detected in the epithelium 
and lamina propria of the respiratory mucosa inocu-
lated with both B1648 and M41 (Figure 1A). In the epi-
thelium, the average number of B1648 infected KUL01+ 
Figure 1 IBV infected cell quantification (A) and antigen expression (B) in tracheal mucosa explants. A Number of IBV B1648 and M41 
infected cells and infected KUL01+ cells were quantified in the epithelial layer and lamina propria of tracheal mucosa explants. Fifteen consecutive 
cryosections were analysed at 0, 6, 12, 24, 48 and 72 hpi to quantify infected cells. The number of infected KUL01+cells starts to increase from 12 
hpi, when the total number of IBV infected cells starts to decrease. Lines represent the evolution of arithmetic means without any transformation 
of original data. Solid line represents mean values of B1648, dashed line represents mean values of M41 and dotted line represents mean values of 
mock. An asterisk (*) indicates a significant difference (P < 0.05) between B1648 and M41. B Representative confocal photomicrograph illustrating 
IBV infected cells (left panel) in the epithelium (arrows) and lamina propria (arrowheads), and IBV infected KUL01+cell (middle panel) in lamina pro-
pria (arrowhead) of the tracheal mucosa. Mock-inoculated tracheal mucosa (right panel). Green fluorescence visualises IBV antigens. KUL01+ cells 
are visualised by red fluorescence. Cell nuclei were stained with Hoechst (blue). White dotted line indicates the BM. Scale bar represents 50 μm.
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cells was slightly higher than M41 infected KUL01+ 
cells at 24 and 48  hpi (P  =  0.2302–0.0705) but signifi-
cantly higher at 72 hpi (P = 0.0270). In the lamina pro-
pria, the average number of B1648 infected KUL01+ cells 
was higher than M41 infected KUL01+ cells at 12, 24, 48 
and 72 hpi (P = 0.0686–0.0550). Interestingly, the num-
ber of infected KUL01+ cells (monocytic cells) started 
to increase from 12  hpi, when the total number of IBV 
infected cells started to decrease. Representative images 
of IBV infected cells and IBV infected KUL01+ cells are 
given in Figure 1B.
The above results indicate that in the epithelium B1648 
replicated better than M41 until 24 hpi. Then, the repli-
cation pattern changed. B1648 exploited more infected 
KUL01+ cells but without significant differences with 
M41 in most of the times post inoculation evaluated.
IBV B1648 and M41 replication in blood monocytic cells 
(KUL01+ cells)
The replication kinetics of IBV B1648 and M41 were 
compared in the peripheral blood monocytic cells 
(KUL01+ cells) (Figure 2). In blood monocytes (KUL01+ 
cells), the percentage of B1648 infected cells was sig-
nificantly higher than M41 infected cells at 12 (B1648: 
9.7  ±  1.3%, M41: 2.2  ±  1.9%, P  =  0.0051), 24 (B1648: 
16.0 ±  2.6%, M41: 2.3 ±  1.5%, P =  0.0013), 48 (B1648: 
21.1 ±  6.0%, M41: 1.4 ±  1.7%, P =  0.0053) and 72  hpi 
(B1648: 46.0 ± 8.6%, M41: 2.2 ± 1.7%, P = 0.0010). Virus 
titers were analyzed in the cell lysate (intracellular virus) 
and supernatant (extracellular virus) of the infected 
blood monocytes. The intracellular and extracellular 
B1648 virus titers increased over time until 24 hpi, and 
later reached a plateau or slightly decreased up to 72 hpi. 
The intracellular virus titers with strain B1648 were sig-
nificantly higher than M41 strain at 12 (P = 0.0115), 24 
(P =  0.0152), 48 (P =  0.0014) and 72  hpi (P =  0.0063). 
The extracellular titers with B1648 were higher than 
with M41 at 12 hpi (P = 0.0501), and were significantly 
higher at 24 (P  =  0.0077), 48 (P  =  0.0118) and 72  hpi 
(P = 0.0270). On the contrary, no increase in viral titers 
was seen in cell lysate and supernatant of blood mono-
cytic cells infected with M41, with a slope compara-
ble to the inactivation curve. Over all, the above results 
demonstrated that only B1648 could establish a produc-
tive infection in the peripheral blood monocytic cells 
(KUL01+ cells).
Replication kinetics between B1648 and M41 strains 
in chickens
Clinical signs and water consumption
After inoculation with B1648 and M41, all chickens 
showed signs of illness characterized by depression, 
ruffled feathers, huddling together, tracheal rales, sneez-
ing, coughing and dyspnoea from 2 to 10  dpi. None of 
the control chickens showed any clinical signs during the 
whole experiment. Water consumption was increased in 
the B1648 group (1370.7 g/bird) compared to the control 
group (853.7  g/bird) and the M41 group (792.2  g/bird). 
Reduced body weight gain was observed in the B1648 
group compared to the control group and the M41 group 
(data not shown).
Post mortem findings
Chickens were euthanized at 12  dpi. Tissue samples of 
trachea, lungs, liver, spleen and kidneys were collected 
from all three groups. At necropsy, enlarged kidneys were 
observed in animals of the B1648 group. No lesions were 
observed in kidneys of the M41 group (Figure 3). Gross 
lesions were not observed in trachea, lungs, liver and 
spleen of animals of the B1648, M41 and control groups.
Standardization of SYBR green‑based RT‑qPCR assay for ORF 
1a gene and interpretation of results
SYBR green-based one step RT-qPCR was performed 
to generate a standard curve, using 1:10 serially diluted 
standard RNA templates. The results indicated that 
the standard curve had a wide dynamic range (101–
107 copies/reaction) with the high linear correlation 
(R2  =  0.9999) between the cycle threshold (Ct) value 
and template concentration (Figure  4A). The slope of 
the standard curve was −3.297. The amplification effi-
ciency of the RT-qPCR assay was 102.3%, according to 
the slope of the exponential phase in the amplification 
chart (Figure 4B). Melt curve analysis showed amplifica-
tion of a specific product with a melting peak at 78.31 °C 
(Figure 4C), which was confirmed by the agarose gel elec-
trophoresis analysis. Amplification was not observed in 
the non-template control. RNA extracts from samples 
were analyzed in duplicate reactions. Quantification of 
the viral RNA copies was possible if the Cq values of both 
reactions fell within the LDR of the RT-qPCR assay. Sam-
ples with a specific melt curve were considered positive 
but not quantifiable when the Cq value of the reactions 
fell at Cq values higher than the lowest peak of the LDR.
RT‑qPCR for tracheal secretions, plasma and mononuclear 
cells
Viral RNA in tracheal secretions, plasma and mono-
nuclear cells was quantified by RT-qPCR (Figure  5). 
The virus-shedding pattern in tracheal mucosa was the 
same until 10 dpi for both B1648 and M41. Viral shed-
ding in tracheal mucosa was identified from 2 to 12 dpi 
in the B1648 group with a maximum number of 106.8 
viral RNA copies/100  mg, and from 2 to 10  dpi in the 
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M41 group with a maximum number of 107.0 viral RNA 
copies/100  mg. In the B1648 group, two chickens were 
positive at 10 and 12 dpi. Two chickens were positive at 
1 dpi, in the M41 group. In tracheal secretions, viral RNA 
copies were not significantly different between the B1648 
and M41 groups.
In plasma, viral RNA was first detected in the B1648 
group at 2  dpi and was observed until the end of the 
study (12 dpi, n =  2), with a peak number of 104.5 viral 
RNA copies/mL. In the M41 group, viral RNA was not 
detected in plasma, except of one animal at  dpi (n = 1, 
102.6 viral RNA copies/mL).
In mononuclear cells, viral RNA was first detected in 
the B1648 group at  dpi and lasted until 8 dpi (n = 2) 
with a peak number of 104.4 viral RNA copies/106 cells. 
In contrast, viral RNA was not detected in mononu-
clear cells of the M41 inoculated animals, except of 
one chicken at 6 dpi (n = 1, 102.8 viral RNA copies/106 
cells).
The statistical analysis was not performed on viral RNA 
copies in plasma and mononuclear cells because the M41 
group was negative except of one chicken at 6 dpi.
Immunostainings of cytospinned mononuclear cells
Immunofluorescence stainings of 200  000 cytospinned 
mononuclear cells revealed B1648 infected cells at 2 
(2/3 animals), 4 (3/3) and 6 (2/3) dpi, and B1648 infected 
KUL01+ cells at 4 (1/3) and 6 (1/3) dpi. Infected cells 
were not observed in cytospinned mononuclear cells of 
M41 and control groups (Figure 6).
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Figure 2 IBV replication kinetics in blood monocytes (KUL01+ cells). The monocytes were inoculated with IBV B1648 or M41 at a m.o.i. = 5. 
Percentage of viral antigen positive KUL01+ cells was determined in B1648 and M41 infected blood mononuclear cells at 0, 6, 12, 24, 48 and 72 
hpi by double immunofluorescence. For viral antigen positive cells, the solid line represents the mean values of the B1648 group, the dashed line 
represents the mean values of the M41 group and the dotted line represents the mean values of the mock group. Intracellular and extracellular 
virus titers of cell lysate and supernatant were determined at designated time points. For viral titers, the solid line represents the mean values of the 
intracellular virus titers, the dashed line represents the mean values of the extracellular virus titers and the dotted line represents the mean values of 
the inactivation curve. An asterisk (*) indicates a significant difference of viral antigen positive KUL01+ cells between B1648 and M41 (P < 0.05). The 
inactivation curve shows the drop of virus titers at 37 °C in culture medium due to inactivation events.
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Virus isolation in plasma and mononuclear cells
To demonstrate the presence of infectious virus from 
plasma and mononuclear cells of infected animals, virus 
isolation was performed by several passages on 10  days 
old embryonated B1648 inoculated eggs [22]. After two 
blind passages, plasma of all B1648 inoculated animals 
at 2, 4, 6, 8, 10 and 12 dpi and mononuclear cells of all 
B1648 inoculated animals at 2, 4, 6 and 8 dpi caused clear 
dwarfing and curling of inoculated embryos (Table  3). 
With mononuclear cells of the B1648 group, lesions 
were observed in one out of three chickens at 10 and 
12  dpi, after two blind passages. Even after five blind 
passages, plasma and mononuclear cells from the M41 
group showed no embryonic lesions, demonstrating the 
absence of infectious virus.
RT‑qPCR and immunofluorescence staining of tissues
Viral RNA was measured in samples of trachea, lungs, 
liver, spleen, and kidneys by RT-qPCR (Figure  7). Viral 
RNA was present in all collected tissues of the B1648 group 
and, only in tracheal samples of the M41 group (B1648: 
104.9 ± 0.5 copies/g, M41: 103.4 ± 0.5 copies/g). The average 
B1648 viral RNA content in the lungs, liver, spleen and 
kidneys were 105.8 ± 1.0, 103.0 ± 2.6, 105.5 ± 0.5 and 108.1 ± 0.3 
copies/g, respectively. Immunofluorescence staining was 
performed on tissues to quantify viral antigen positive 
Figure 3 Representative photographs of kidneys after euthanasia (12 dpi). Kidneys were collected from chickens inoculated with IBV 
B1648 and M41, and PBS (mock). The kidneys of the chicken infected with B1648 were clearly enlarged.
Figure 4 Standardization of SYBR green-based RT-qPCR for ORF 1a gene. A Standard curve, B amplification plot and C melt curve analysis 
over a linear dynamic range from 1 log10 to 7 log10 copies/reaction.
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cells (Figure  8). IBV infected cells were detected in the 
tracheal mucosa of animals inoculated with both strains 
(B1648: 0.33 ± 0.06/10 mm2, M41: 0.40 ± 0.33/10 mm2) 
and in the lungs (0.96  ±  0.13/10  mm2), liver 
(1.86 ± 0.80/10 mm2), spleen (1.81 ± 1.16/10 mm2) and 
kidneys (85.71 ±  12.06/10  mm2) of only animals inocu-
lated with B1648.
Discussion
Despite the circulation of nephropathogenic and res-
piratory IBV strains for over five to six decades, it is 
not well understood why some IBV strains have a kid-
ney tropism [3, 7, 15]. Hence, we have investigated the 
replication patterns of IBV nephropathogenic (B1648) 
and respiratory (M41) strains in  vitro, in respiratory 
mucosa explants and peripheral blood monocytes, and 
in chickens.
The replication kinetics and invasion strategies of IBV 
B1648 and M41 were better understood by the work 
done with respiratory mucosa explants. Similar to many 
other IBV viruses, B1648 and M41 are epitheliotropic 
in the respiratory mucosa [3, 5, 7]. Replication kinetics 
of B1648 and M41 in the respiratory mucosa explants 
have revealed some important differences between these 
strains. B1648 replicated somewhat better than M41 in 
the epithelium of the respiratory mucosa at 6, 12 and 
24  hpi (P  <  0.05). Consequently, B1648 destroyed the 
epithelial layer more severely than M41. The desquama-
tion of the cells present in the epithelial layer is the main 
























































































Figure 5 IBV RNA in tracheal secretions, plasma and mononuclear cells. Samples were collected from IBV B1648 and M41, and PBS (mock) 
inoculated chickens at 0, 2, 4, 6, 8, 10 and 12 dpi. Viral RNA was measured by RT-qPCR. Solid and dashed lines represent mean viral RNA copies 
per strain and per day. Mock is represented by the dash-dotted line. The quantification limit of RT-qPCR was 3.4 log10 copies/mL (dotted line). The 
detection limit of RT-qPCR was 2.4 log10 copies/mL (bold dotted line).






























Figure 6 Quantification and identification of IBV B1648 and 
M41 infected total and KUL01+ PBMC. IBV B1648 and M41, and 
PBS (mock) inoculated blood samples were collected at 0, 2, 4, 6, 8, 10 
and 12 dpi; 200 000 mononuclear cells were cytospinned and immu-
nostainings were performed. B1648+ infected PBMC were observed 
at 2, 4 and 6 dpi and KUL01+B1648+ infected cells were observed at 
4 and 6 dpi.
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reason for the decreased number of IBV infected cells 
after 24 hpi [30]. Above results indicated that B1648 was 
highly virulent compared to M41 in the epithelial layer of 
respiratory mucosa.
There have been several reports on the virulence of IBV 
strains in in vitro tracheal organ cultures. Chhabra et al. 
[31] and Raj and Jones [32] have reported that in tracheal 
organ cultures, the M41 strain was highly pathogenic 
compared to the variant nephropathogenic IS/885/00-like 
and QX-like IBV strains and other variant strains (Strain 
G and strain 6/1432/81) [9, 33]. In addition, Abd El Rah-
man et  al. [34] have shown that Beaudette (highly pas-
saged Massachusetts-derived strain) and QX were highly 
pathogenic compared to Italy 02 and 4/91 variant strains. 
According to the above in vitro reports, M41 strain used 
in the present study seems to be somewhat less virulent 
than other M41 strains reported in literature [31, 32].
Although speculative, a hypothesis can be formed to 
explain the lower virulence of M41 strain in vitro, which 
was used in the present study. The passage history of 
the strain and genome sequence should be considered. 
The passage history of the present study M41 strain is 
unknown [21, 22]. For IBV isolation from infected chick-
ens, sometimes several passages of the strain in embry-
onated eggs are necessary to observe characteristic 
clinical signs of infection on embryos [22]. The repeated 
passages may alter the virulence and antigenicity of the 
virus [22]. If the present study M41 strain has been seri-
ally passaged in the past, then it may have lost part of its 
replication ability, and it may not be able to replicate or 
show virulence to the extent that is associated with other 
reported M41 strains [31, 32]. Therefore, it is impor-
tant to give more emphasis on the passage history of the 
strains to have a better understanding about their viru-
lence and its associated biological properties [35]. The 
genome sequence of the present study M41 strain may 
be different from those of the M41 strains reported by 
Chhabra et al. [31], Raj and Jones [32] and Abd El Rah-
man et al. [34]. At present, there is no information avail-
able on the full genome sequence of M41 strain used in 
the present study. In the future, our M41 strain will be 
sequenced and analyzed. However, in contrast with the 
in  vitro findings, our M41 was replicating better than 
the B1648 IBV strain in vivo demonstrating the fitness of 
our M41 in birds. Therefore, one should be careful with 
overinterpreting the in vitro results.
Similar replication differences were observed in tracheal 
organ cultures with many other IBV strains and serotypes 
[32, 36, 37]. In general, the differences in virulence of 
strains at the respiratory mucosa might be related to the 
presence/absence, and/or differential expression of recep-
tors on susceptible epithelial cells, antiviral responses of 
the host cells and immune-evasion mechanisms devel-
oped by the IBV strain [38]. It would be interesting to 
compare the replication kinetics in in  vitro tracheal 
mucosa explants, between B1648 and other worldwide 
important IBV strains such as variant nephropathogenic 
IS/885/00-like and QX-like strains, recent variant M41 
strains and variant Italy 02 and 4/91 strains [7].
Table 3 Virus isolation of plasma and mononuclear cells
Plasma and mononuclear cells were collected from chickens at different time points post inoculation with IBV B1648 and M41. Virus isolation was performed by 
inoculating embryonated eggs.
Samples IBV strain Number of positive animals per three inoculated animals at … days post inoculation
0 2 4 6 8 10 12
Plasma B1648 0/3 3/3 3/3 3/3 3/3 3/3 3/3
M41 0/3 0/3 0/3 0/3 0/3 0/3 0/3
Control 0/3 0/3 0/3 0/3 0/3 0/3 0/3
Mononuclear cells B1648 0/3 3/3 3/3 3/3 3/3 1/3 1/3
M41 0/3 0/3 0/3 0/3 0/3 0/3 0/3
Control 0/3 0/3 0/3 0/3 0/3 0/3 0/3


























Figure 7 Viral RNA copies in the trachea, lungs, liver, spleen 
and kidneys at 12 dpi. Tissues were collected at euthanasia (12 dpi) 
from chickens inoculated with IBV B1648 and M41, and PBS (mock). 
Viral RNA copies (log10 viral RNA copies/g of tissue) were measured 
by RT-qPCR. The quantification limit of RT-qPCR was 3.4 log10 copies/
mL (dotted line). The detection limit of RT-qPCR was 2.4 log10 copies/
mL (bold dotted line).
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Figure 8 IBV infected cell localization (A) and quantification (B) in various tissues at 12 dpi. Trachea, lungs, liver, spleen and kidneys were 
collected from IBV B1648 and M41, and PBS (mock) inoculated chickens at 12 dpi. A Representative confocal photomicrographs illustrating viral 
antigen positive cells (arrowheads). Green fluorescence visualises IBV antigens. Cell nuclei were stained with Hoechst (blue). Scale bar represents 
50 μm. B Quantification of viral antigen positive cells was performed per 20 consecutive cryosections of 10 μm tissue. Viral antigen positive cells 
were quantified in the tracheal mucosa of B1648 and M41 infected animals and in the lungs, liver, spleen and kidneys of only B1648 infected 
animals. The average number of viral antigen positive cells present in different tissues is presented per 10 μm2. For each tissue, mean and standard 
deviation (SD) are shown.
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During the epithelial cell layer infection, both B1648 
and M41 infected cells penetrated through the basement 
membrane (BM) into the lamina propria. The number of 
B1648 viral antigen positive cells in the lamina propria 
was quite higher than the number of M41 viral antigen 
positive cells at 6, 12, 24 and 48 hpi, and was significantly 
higher at 72  hpi (P  <  0.05). Certain infected cells were 
identified as KUL01+ cells (monocytic cells) and, whose 
number started to increase from 12 hpi, where the total 
number of IBV infected cells started to decrease. It could 
be that the infected monocytic cells (KUL01+ cells) that 
increased after 12  hpi, started to cross the BM to enter 
the lamina propria and underlying layers. These infected 
monocytic cells (KUL01+ cells) may play a crucial role in 
dissemination of virus to the blood circulation and inter-
nal organs. Therefore, monocytic cells may be identi-
fied as carrier cells that breach through the BM to reach 
underlying layers of the respiratory mucosa. The use of 
monocytic cells by nephropathogenic IBV as a Trojan 
horse to penetrate through connective tissues is in line 
with what has been observed with equine herpes virus 
1 (EHV1) and European equine arteritis virus in the res-
piratory mucosa of horses [16, 17, 39, 40]. In our study, 
many infected cells in the epithelium and lamina propria 
were observed. Because only a certain percentage was 
identified as KUL01+, efforts will be made to identify the 
KUL01 negative IBV infected cells in the propria of tra-
cheal mucosa explants.
The percentage of infected peripheral blood mono-
cytes (KUL01+ cells) and virus production was higher 
(P  <  0.05) with B1648 than with M41 at 12, 24, 48 and 
72  hpi. The intracellular and extracellular titers showed 
that B1648 has a strong productive replication in the 
peripheral blood monocytes. The decrease or no change 
in the intracellular and extracellular virus titers of B1648 
strain at 48 and 72 hpi may be due to the absence of avail-
able susceptible cells or due to an antiviral response (e.g. 
interferon). This is in line with the MERS-CoV and den-
gue virus interactions with human macrophages, and 
classical swine fever virus interactions with monocyte 
derived dendritic cells [41–43]. Absence of increase of 
percentage of infected cells and virus titers in the cell 
lysate and supernatant with M41 demonstrated that 
the M41 infection of monocytes was abortive. The pro-
ductive replication of B1648 and abortive replication of 
M41 is most probably the result of differences at certain 
steps of the replication cycle (entry, disassembly, genome 
release, transcription, translation and assembly). This 
issue will be further explored in the future.
In general, coughing, dyspnea, tracheal rales, depres-
sion, ruffled feathers and huddling together are char-
acteristic clinical signs of IB in chickens [1]. Increased 
water consumption is a typical clinical sign of 
nephropathogenic IB and was recorded in the B1648 
group [9, 30]. Reduced body weight gain was another 
important clinical sign noticed in the B1648 group (data 
not shown). At postmortem, swollen kidneys were prin-
cipal macroscopic lesions recorded in the B1648 group, 
which is consistent with other nephropathogenic strains 
[1].
RT-qPCR is a reproducible and reliable method for 
rapid quantification of IBV RNA in clinical samples [44–
46]. At present, most of the available RT-qPCR assays, 
which target the nucleocapsid gene, 5′ untranslated 
region, or the S1 gene of the IBV genome are not effi-
cient to quantify B1648 and M41 strains in a consistent 
way, by the highly flexible and cost effective SYBR green 
method [44–46]. Other RT-qPCR assays that target the 3′ 
end of the viral genome [47–49], usually give a 3–4 log10 
overestimation of viral genomic RNA, as this 3′ RT-qPCR 
detects not only genomic RNA, but also all subgenomic 
mRNAs [19]. Indeed, during coronavirus replication, 
RNA dependent RNA polymerase synthesizes genomic 
RNA, as well as minus strand and subgenomic mRNAs. 
Based on our past experience with feline coronavirus 
quantification, 5′ RT-qPCR is the most consistent and 
reliable quantification method, because it evades over-
estimation of genomic RNAs than 3′RT-qPCR [19, 50]. 
Thus, 5′ RT-qPCR was developed to avoid quantification 
of the subgenomic mRNAs.
After inoculation of virus, both B1648 and M41 initiate 
extensive virus replication in the epithelium of the upper 
respiratory tract (URT) and shed virus in the respiratory 
secretions between 2 to 12 dpi. In contrast to the in vitro 
results in tracheal mucosa explants, the replication of 
B1648 and M41 were very similar except that B1648 rep-
lication was persisting longer (12 dpi). It would have been 
interesting, if tracheal swabs and mucosal tissues were 
collected at 6, 12, 24, 48 and 72  hpi (similar to in  vitro 
experiments) to better understand the infection kinetics 
at the epithelial layer and lamina propria layer of in vivo 
tracheal mucosa and to compare it with in vitro results. 
The primary local replication of both B1648 and M41 at 
the URT allows horizontal transmission virus to suscepti-
ble birds and ensures virus circulation in birds [51].
Viral RNA was detected in plasma of B1648 inoculated 
animals at 2 (n = 3), 4 (n = 3), 6 (n = 3), 8 (n = 3), 10 
(n = 3) and 12 dpi (n = 2) at a concentration of 102.4–4.5 
and in mononuclear cells of B1648 inoculated animals 
at 2 (n =  3), 4 (n =  3), 6 (n =  3) and 8 (n =  2) dpi at 
a concentration of 101.8–4.4 viral RNA copies/106 mono-
nuclear cells. These B1648 viral RNA copies of plasma 
and mononuclear cells were originated from infectious 
virus as confirmed by virus isolation. In M41 inoculated 
animals, viral RNA was present in only one animal at 6 
dpi in plasma and mononuclear cells but no infectious 
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virus could be demonstrated by virus isolation. Infected 
cells were demonstrated by immunofluorescence in cyto-
spinned mononuclear cells at 2 (n  =  2), 4 (n  =  3) and 
6 dpi (n = 2) with B1648. M41 infected cells were never 
demonstrated. These results demonstrated the onset of a 
cell free and cell-associated viremia at 2 dpi with B1648. 
This indicates that cell free B1648 virus and/or B1648 
infected cells are able to enter into the blood circulation 
very quickly. The potential spread of B1648 from blood 
into the internal organs was demonstrated. In contrast 
with B1648, infectious virus was not demonstrated for 
M41 to reach the blood circulation and internal organs. 
Pseudorabies virus and classical swine fever virus are 
other examples of viruses that result in a combination of 
cell free and cell-associated viremia leading to the viral 
spread in mammals [52, 53]. For many avian viral infec-
tions, there is no information on the viremic phase and 
its pathogenic consequences.
The infected mononuclear cells were mainly KUL01+ 
cells but also some KUL01 negative cells were present. 
The latter were not identified. They could be unidenti-
fied blood monocytic cells (KUL01 negative), B and T 
lymphocytes. The KUL01 marker is not reported to iden-
tify all the monocytic cells of the blood circulation [24]. 
Hence, the role of blood dendritic cells, KUL01 negative 
monocytic cells, B and T lymphocytes in B1648 infec-
tion kinetics and dissemination needs to be elucidated in 
future work.
In the B1648 group, cell-free virus in plasma persisted 
until the end of the study (12 dpi). Different sources 
may have continuously contributed to the cell-free 
virus in plasma during the course of B1648 infection. 
At early time points (2 and 4 dpi), cell free virions pro-
duced by tracheal epithelial cells may have infiltrated 
into the underlying submucosal layers. Then, through 
capillaries cell-free virions may have reached blood cir-
culation. At 6 and 8  dpi, infected blood mononuclear 
cells may have released virus in plasma. The presence 
of infectious virus in plasma at later time points (10 
and 12 dpi) but not in mononuclear cells indicated that 
cell free virions from infected internal organs may have 
leaked into the blood circulation. In the M41 group, the 
absence of viral RNA and infectious virus, especially at 
later time points (8, 10 and 12 dpi), is also an indication 
that infectious virus could not have reached internal 
organs.
Viral RNA and antigen positive cells were only detected 
in lungs, liver, spleen and kidneys of B1648 infected ani-
mals at 12  dpi, demonstrating that only B1648 was dis-
seminated through the mononuclear cells and plasma 
but not M41 at that stage of infection. In the M41 group, 
the possibility of presence of viral RNA and antigen posi-
tive cells in tissues at earlier time points (6, 8 and 10 dpi) 
cannot be completely excluded. B1648 replicated more 
productively in the kidneys compared to lungs, liver 
and spleen, illustrating the high nephropathogenicity of 
B1648 [7, 13, 14]. Infected KUL01+ cells (colocalization) 
were not observed in the tissues. This demonstrates that 
once the virus reached internal organs, it is replicating in 
non-KUL01+ cells [7]. In kidneys it is known that it repli-
cates in tubular cells.
In this study, we observed several differences between 
B1648 and M41 strains at the level of mononuclear cells 
(KUL01+ cells). Firstly, the number of B1648 infected 
KUL01+ cells in the lamina propria of in  vitro tracheal 
mucosa explants was quite higher than M41. Secondly, 
the percentage of infected cells and virus production in 
the in vitro inoculated blood mononuclear cells (KUL01+ 
cells) was higher for B1648 than for M41. Thirdly, viral 
RNA copies were detected in mononuclear cells of all 
B1648 infected chickens and exceptionally with M41. 
The results above implicate that monocytic cells may 
be important carrier cells, which are required for the 
progress of B1648 disease. The productive and sustain-
able replication of B1648 virus in blood monocytic cells 
(KUL01+ cells) may represent an important strategy used 
by B1648 to disseminate virus to the kidneys and other 
internal organs. In mammals, many highly pathogenic 
viruses or virus strains exploit and replicate productively 
in macrophages to cause severe systemic disease [43, 
54–56]. Because monocytes/macrophages are usually the 
first line of defense against virus entry, the successful rep-
lication of virus in these cells may hamper their immuno-
logical functions and by the migratory characteristics of 
these cells, virus is disseminated throughout the body. In 
this context, monocytes are considered as double edged 
swords [57–59].
Even though M41 infected KUL01+ cells were observed 
in the lamina propria of the tracheal mucosa explants, the 
abortive replication of M41 in monocytic cells (KUL01+ 
cells) most probably hampered the dissemination of M41 
via blood to reach the kidneys and other internal organs. 
Furthermore, the replication ability of M41 may be low-
est in the lamina propria and underlying layers to release 
cell free virus. Therefore, it can be stated that the M41 
strain that was used in the present study can replicate 
only in the respiratory mucosa, and cannot spread to 
the internal organs for further disease progression. The 
results presented here are somewhat different with those 
from other reports, where Massachusetts type strains 
(M41) were detected in kidneys [60, 61]. Some other 
studies with the M41 reference strain have shown only 
mild histopathological lesions with the absence of viral 
antigen positive cells [62]. The basis for the differences 
between the different studies is not clear but might be 
due to different M41 strains, passage levels, experimental 
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Figure 9 Hypothetical model of IBV B1648 and M41 replication kinetics in respiratory mucosa, blood and internal organs of chick-
ens. Stars represent infectious virus. Star number and infectivity are directly proportional to each other. After natural entry of virus through nostrils, 
both nephropathogenic IBV B1648 and M41 replicate in the tracheal mucosa. B1648 uses a higher number of infected KUL01+ cells as carriers to 
penetrate deeper in the layers of the respiratory mucosa in contrast to M41. B1648 productively infects KUL01+ blood monocytic cells while M41 
infection is abortive. Only B1648 disseminates via a cell-associated viremia in mononuclear leukocytes and cell free virus in plasma to reach lungs, 
liver, spleen and kidneys. B1648 productive infection is present in kidneys and to a less degree in lungs, liver and spleen.
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design and conditions, nutrition, environment, intercur-
rent infections, age/breed of the birds, and detection 
techniques [30, 63].
Otherwise, M41 strains used in recent reports might 
be mutants/variants of the prototype M41. Mutation 
and recombination events are common in coronavi-
ruses, which are likely to contribute to the emergence 
of new variants/mutants and outbreaks of new diseases 
[64]. Currently, at least 8 full genome sequences of M41 
are available in Genbank. The full genome sequence of 
the latest M41_2006 was closest (90.8%) to the B1648 full 
genome sequence compared to earlier Mass 41_1965-
85 (89.7%) full genome sequences [15]. It could be that 
the recent M41 strains may be recombinant viruses like 
M41_2006 with only the spike gene from the prototype 
M41 and the remaining genome regions from Con-
necticut and California serotypes [65]. The Mass type 
(M41) is identified/classified based on the sequence of its 
spike gene (3500 bp) only, but one should consider that 
remaining genomic regions (24 000 bp) may also play an 
important role in the pathogenicity of the virus [15, 66]. 
Thus, in the near future, full sequences should be consid-
ered and not only parts of it. Therefore, the full genome 
sequence of the M41 strain used in the present study will 
be elucidated to understand its evolutionary relationship 
with other Massachusetts type strains.
The cell-associated viremia in mononuclear leukocytes 
and cell free virus in plasma and the replication in kid-
neys of B1648 virus infected chickens is very similar to 
another coronavirus, MERS-CoV in humans. MERS-CoV 
was also reported in whole blood and plasma of humans 
[67–69]. In addition, MERS-CoV is replicating in mono-
cytic cells and kidneys, resulting in high mortality in 
humans [43, 67–70].
In summary, B1648 and M41 strains followed differ-
ent tissue tropism mechanisms (Figure  9). Both B1648 
and M41 strains successfully invade and replicate in the 
epithelium of the respiratory mucosa. B1648 uses more 
mononuclear cells as carrier cells to breach through the 
underlying layers of the respiratory mucosa. The penetra-
tion through the deeper layers of the respiratory mucosa 
was more intensive with B1648 compared to M41. 
B1648 spreads via a cell free and cell-associated viremia 
to target organs such as kidneys, liver, spleen and lungs 
whereas M41 does not do this. B1648 showed a fully pro-
ductive replication in the KUL01+ blood monocytic cells. 
B1648 replication was more productive in kidneys and 
less in liver, spleen and lungs. During M41 infection, the 
infected KUL01+ cells could not be able to infiltrate into 
the circulation or were abortive in the submucosal layers 
of the upper respiratory tract (trachea and bronchi). Our 
study unveils hitherto unknown, but crucial aspects of 
the tissue tropism of B1648 and M41 strains. B1648 has 
achieved highly nephropathogenic hallmarks by exploit-
ing the carrier mononuclear cells in an active manner, 
whereas M41 is not nephropathogenic due to the abor-
tive nature of M41 infection of mononuclear cells.
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